Innovent Biologics Funding History

Since Innovent Biologics was founded in 2011, it has participated in 7 rounds of funding. In total Innovent Biologics has raised $1.3B. Innovent Biologics' last funding round was on Oct 2019 for a total of $300.0M.

Innovent Biologics Funding Rounds

Secondary Offering

Oct 2019

$300M

IPO

Oct 2018

$421M

Series E

Apr 2018

$150M

Capital Group Private Markets, Rock Springs Capital, Ally Bridge Group, Temasek, Hillhouse, Legend Capital, Lilly Asia Ventures, Taikang Insurance

Series D

Nov 2016

$260M

State Development & Investment Corporation, China Life Private Equity Limited, Hillhouse Capital Group, Legend Capital, Temasek Holdings, Taikang Life Insurance

Series C

Jan 2015

$100M

Legend Capital, Temasek Holdings, Fidelity Growth Partners Asia, Lilly Asia Ventures, Frontline Bioventures

Innovent Biologics Investors

Capital Group Private Markets

Series E

Apr 2018

Rock Springs Capital

Series E

Apr 2018

Ally Bridge Group

Series E

Apr 2018

Temasek

Series E

Apr 2018

Hillhouse

Series E

Apr 2018

Innovent Biologics has 16 investors, including Capital Group Private Markets, Rock Springs Capital and Ally Bridge Group. The latest investment occurred in Oct 2019.

Innovent Biologics Funding History

Since Innovent Biologics was founded in 2011, it has participated in 7 rounds of funding. In total Innovent Biologics has raised $1.3B. Innovent Biologics' last funding round was on Oct 2019 for a total of $300.0M.

Innovent Biologics Funding Rounds

ROUND

FUNDING DATE

AMOUNT

NUMBER OF INVESTORS

INVESTORS

Total Funding: $1.3B

Innovent Biologics Investors

INVESTOR

ROUND

FUNDING DATE

Total Investors: 16